Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MacDonald

Showing results (911-920 of 1,067) with videos related to

Pageof 107
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trialsEric Raymond, Carmen Kahatt, Marie Hélène Rigolet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Phase I and pharmacokinetic study of irofulven administered weekly or biweekly in advanced solid tumor patientsJérôme Alexandre, Eric Raymond, Mahmoud Ould Kaci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Circulation. Heart Failure|October 8, 2009
Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in ScotlandMichael R MacDonald, Pardeep S Jhund, Mark C Petrie, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Chen Hu, David R Macdonald, et al.
Diabetes Care|May 13, 2011
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMichael R MacDonald, Mark C Petrie, Philip D Home, et al.
European Journal of Heart Failure|April 5, 2011
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment studyColette E Jackson, Michael R MacDonald, Mark C Petrie, et al.
Antiviral Research|September 27, 2020
Generation of a reporter yellow fever virus for high throughput antiviral assaysRicardo Sanchez-Velazquez, Giuditta de Lorenzo, Rapeepat Tandavanitj, et al.
Plos Pathogens|January 7, 2017
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP)Melody M H Li, Zerlina Lau, Pamela Cheung, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 4, 2024
Prevalence of Powassan Virus Seropositivity Among People with History of Lyme Disease and Non-Lyme Community Controls in the Northeastern United StatesTania Kapoor, Lilly Murray, Maria Kuvaldina, et al.
Pageof 107

Showing results (911-920 of 1,067) with videos related to

Sort By:
Pageof 107
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trialsEric Raymond, Carmen Kahatt, Marie Hélène Rigolet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Phase I and pharmacokinetic study of irofulven administered weekly or biweekly in advanced solid tumor patientsJérôme Alexandre, Eric Raymond, Mahmoud Ould Kaci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Circulation. Heart Failure|October 8, 2009
Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in ScotlandMichael R MacDonald, Pardeep S Jhund, Mark C Petrie, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Chen Hu, David R Macdonald, et al.
Diabetes Care|May 13, 2011
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMichael R MacDonald, Mark C Petrie, Philip D Home, et al.
European Journal of Heart Failure|April 5, 2011
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment studyColette E Jackson, Michael R MacDonald, Mark C Petrie, et al.
Antiviral Research|September 27, 2020
Generation of a reporter yellow fever virus for high throughput antiviral assaysRicardo Sanchez-Velazquez, Giuditta de Lorenzo, Rapeepat Tandavanitj, et al.
Plos Pathogens|January 7, 2017
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP)Melody M H Li, Zerlina Lau, Pamela Cheung, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 4, 2024
Prevalence of Powassan Virus Seropositivity Among People with History of Lyme Disease and Non-Lyme Community Controls in the Northeastern United StatesTania Kapoor, Lilly Murray, Maria Kuvaldina, et al.
Pageof 107